Company profilePharmaceutical#185 of 1,318 in Pakistan✓ No DRAP alerts

ARP (PVT) Limited

Pharmaceutical company · 95 brands · 75 molecules

Ranked #77 of 137 companies in Anti-Infectives

95 registered products 52 pharmaceutical brands 75 distinct molecules 0 DRAP alerts

Company overview

95
registered products
52
pharmaceutical brands
75
distinct molecules
1
therapeutic classes
0
DRAP alerts

ARP (PVT) Limited is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 95 product registrations across 75 distinct molecules. It is the 185th largest registrant in Pakistan by product count, and ranks 77th of 137 in Anti-Infectives. Its portfolio is concentrated in Anti-Infectives. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by ARP

72 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

70
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202670

Top molecules by brand count

Ceftriaxone6 brands
Linezolid5 brands
Quetiapine5 brands
Cefixime5 brands
Paroxetine5 brands
Olanzapine4 brands
Risperidone4 brands
Azithromycin4 brands
Omeprazole3 brands

Therapeutic classes

Anti-Infectives · 1

Conditions treated

General Infections · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official114 products · Rs 85.47 – Rs 12,397.14
Servaid3 products · Rs 165 – Rs 323
Median across source: Rs 534.74

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 111 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
NABIQASIM INDUSTRIES (PVT) LTD. holds 167 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir
HIGH - Q INTERNATIONAL holds 117 molecules not in this portfolio
000 I.UAcetyl L-CarnitineAmikacinAmlodipineAnastrozoleAprepitant

Get the full profile for ARP

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.